Pharmaceutical Russia is interested in launching production of its vaccine against COVID-19 in Brazil at the facilities of some of local drugmakers, according to Kirill Dmitriev, head of the Russian Fund of Direct Investments (RFDI), one of Russia’s leading public investment funds and which participated in the project, reports The Pharma Letter’s local correspondent. 25 August 2020